Literature DB >> 23338058

Extracellular adenosine signaling in molecular medicine.

Holger K Eltzschig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23338058      PMCID： PMC3563678          DOI： 10.1007/s00109-013-0999-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  53 in total

1.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.

Authors:  A Ohta; M Sitkovsky
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

2.  Organic compound synthesis on the primitive earth.

Authors:  S L MILLER; H C UREY
Journal:  Science       Date:  1959-07-31       Impact factor: 47.728

3.  Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury.

Authors:  Ulrich Schingnitz; Katherine Hartmann; Christopher F Macmanus; Tobias Eckle; Stephanie Zug; Sean P Colgan; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

4.  Detrimental effects of adenosine signaling in sickle cell disease.

Authors:  Yujin Zhang; Yingbo Dai; Jiaming Wen; Weiru Zhang; Almut Grenz; Hong Sun; Lijian Tao; Guangxiu Lu; Danny C Alexander; Michael V Milburn; Louvenia Carter-Dawson; Dorothy E Lewis; Wenzheng Zhang; Holger K Eltzschig; Rodney E Kellems; Michael R Blackburn; Harinder S Juneja; Yang Xia
Journal:  Nat Med       Date:  2010-12-19       Impact factor: 53.440

5.  Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.

Authors:  Melanie L Hart; Almut Grenz; Iris C Gorzolla; Jens Schittenhelm; Julee H Dalton; Holger K Eltzschig
Journal:  J Immunol       Date:  2011-02-28       Impact factor: 5.422

6.  Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity.

Authors:  Ditte Lovatt; Qiwu Xu; Wei Liu; Takahiro Takano; Nathan A Smith; Jurgen Schnermann; Kim Tieu; Maiken Nedergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

7.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

8.  Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis.

Authors:  Julia-Stefanie Frick; Christopher F MacManus; Melanie Scully; Louise E Glover; Holger K Eltzschig; Sean P Colgan
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.

Authors:  Jörg Reutershan; Irene Vollmer; Stefanie Stark; Rosalyn Wagner; Kristian-Christos Ngamsri; Holger K Eltzschig
Journal:  FASEB J       Date:  2008-10-06       Impact factor: 5.191

10.  HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.

Authors:  Holger K Eltzschig; Parween Abdulla; Edgar Hoffman; Kathryn E Hamilton; Dionne Daniels; Caroline Schönfeld; Michaela Löffler; German Reyes; Michael Duszenko; Jorn Karhausen; Andreas Robinson; Karen A Westerman; Imogen R Coe; Sean P Colgan
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307
View more
  20 in total

Review 1.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

2.  Schwann Cells Metabolize Extracellular 2',3'-cAMP to 2'-AMP.

Authors:  Jonathan D Verrier; Patrick M Kochanek; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2015-05-21       Impact factor: 4.030

Review 3.  Attenuating myocardial ischemia by targeting A2B adenosine receptors.

Authors:  Holger K Eltzschig; Stephanie K Bonney; Tobias Eckle
Journal:  Trends Mol Med       Date:  2013-03-26       Impact factor: 11.951

4.  Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.

Authors:  L Buisseret; S Pommey; B Allard; S Garaud; M Bergeron; I Cousineau; L Ameye; Y Bareche; M Paesmans; J P A Crown; A Di Leo; S Loi; M Piccart-Gebhart; K Willard-Gallo; C Sotiriou; J Stagg
Journal:  Ann Oncol       Date:  2018-04-01       Impact factor: 32.976

5.  Adenosine production by brain cells.

Authors:  Edwin K Jackson; Shawn E Kotermanski; Elizabeth V Menshikova; Raghvendra K Dubey; Travis C Jackson; Patrick M Kochanek
Journal:  J Neurochem       Date:  2017-04-06       Impact factor: 5.372

6.  Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine.

Authors:  Edwin K Jackson; Yumeng Zhang; Dongmei Cheng
Journal:  Hypertension       Date:  2017-01-30       Impact factor: 10.190

Review 7.  The hypoxia-adenosine link during inflammation.

Authors:  Jessica L Bowser; Jae W Lee; Xiaoyi Yuan; Holger K Eltzschig
Journal:  J Appl Physiol (1985)       Date:  2017-08-10

8.  Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.

Authors:  Raghvendra K Dubey; Jürgen Fingerle; Delbert G Gillespie; Zaichuan Mi; Marinella Rosselli; Bruno Imthurn; Edwin K Jackson
Journal:  Hypertension       Date:  2015-09-28       Impact factor: 10.190

Review 9.  Purines: forgotten mediators in traumatic brain injury.

Authors:  Edwin K Jackson; Detlev Boison; Michael A Schwarzschild; Patrick M Kochanek
Journal:  J Neurochem       Date:  2016-02-25       Impact factor: 5.372

Review 10.  Role of purines in regulation of metabolic reprogramming.

Authors:  Zhenwei Tang; Wenrui Ye; Haotian Chen; Xinwei Kuang; Jia Guo; Minmin Xiang; Cong Peng; Xiang Chen; Hong Liu
Journal:  Purinergic Signal       Date:  2019-09-06       Impact factor: 3.765
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.